Molecular characterization of macrolide-and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008)

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 4, 2010, Pages 634-643

  Ardanuy, Carmen ^a,b   Domenech, Arnau ^a   Rolo, Dora ^a,b   Calatayud, Laura ^a,b   Tubau, Fe ^a,b   Ayats, Josefina ^a,b   Martín, Rogelio ^a   Liñares, Josefina ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antimicrobial resistance; Group A streptococci; Transposons

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; JOSAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; QUINUPRISTIN; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL DNA; MACROLIDE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BROTH DILUTION; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HOSPITAL PATIENT; HUMAN; MOLECULAR CLONING; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SPAIN; STREPTOCOCCUS PYOGENES; TRANSPOSON; ADOLESCENT; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 77952567891     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq006     Document Type: Article

References (37)

1. Commons R, Rogers S, Gooding T et al. Superantigen genes in group A streptococcal isolates and their relationship with emm types. J Med Microbiol 2008; 57: 1238-46.
2. Michos AG, Bakoula CG, Braoudaki M et al. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn Microbiol Infect Dis 2009; 64: 295-9.
3. Perez-Trallero E, Montes M, Orden B et al. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother 2007; 51: 1228-33.
4. Silva-Costa C, Pinto FR, Ramirez M et al. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal. Clin Microbiol Infect 2008; 14: 1152-9.
5. Bingen E, Bidet P, Mihaila-Amrouche L et al. Emergence of macrolide-resistant Streptococcus pyogenes isolates in French children. Antimicrob Agents Chemother 2004; 48: 3559-62.
6. De Azavedo JC, Yeung RH, Bast DJ et al. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother 1999; 43: 2144-7.
7. Green MD, Beall B, Marcon MJ et al. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother 2006; 57: 1240-3.
8. Seppälä H, Skurnik M, Soini H et al. A novel erythromycin resistance methylase gene (ermTR)inStreptococcus pyogenes. Antimicrob Agents Chemother 1998; 42: 257-62.
9. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40: 1817-24.
10. Malbruny B, Nagai K, Coquemont M et al. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother 2002; 49: 935-9.
11. Ardanuy C, Tubau F, Liñares J et al. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes. Antimicrob Agents Chemother 2005; 49: 827-9.
12. Calatayud L, Ardanuy C, Cercenado E et al. Serotypes, clones, and mechanisms of resistance of erythromycin-resistant Streptococcus pneumoniae isolates collected in Spain. Antimicrob Agents Chemother 2007; 51: 3240-6.
13. Varaldo PE, Montanari MP, Giovanetti E. Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob Agents Chemother 2009; 53: 343-53.
14. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Growth Aerobically- Seventh Edition: Approved Standard M7-A6. CLSI, Wayne, PA, USA, 2006.
15. Clinical Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18. CLSI, Wayne, PA, USA, 2008.
16. Kataja J, Huovinen P, Skurnik M et al. Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother 1999; 43: 48-52.
17. Brenciani A, Bacciaglia A, Vecchi M et al. Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene. Antimicrob Agents Chemother 2007; 51: 1209-16.
18. Cochetti I, Tili E, Vecchi M et al. NewTn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci. J Antimicrob Chemother 2007; 60: 127-31.
19. Yan SS, Schreckenberger PC, Zheng X et al. An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes. Diagn Microbiol Infect Dis 2008; 62: 205-9.
20. Rivera A, Rebollo M, Miró E et al. Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J Med Microbiol 2006; 55: 1115-23.
21. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial isolate typing. J Clin Microbiol 1995; 33:2233-9.
22. Introduction to emm typing: M protein gene (emm) typing Streptococcus pyogenes. http://www.cdc.gov/ncidod/biotech/strep/ M-ProteinGene_typing.htm (29 December 2008, date last accessed).
23. MLST. http://spyogenes.mlst.net (29 December 2008, date last accessed).
24. Sierra JM, Sánchez F, Castro P et al. Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003. Medicine (Baltimore) 2006; 85: 139-46.
25. Perez-Trallero E, Urbieta M, Montes M et al. Emergence of Streptococcus pyogenes isolates resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis 1998, 17: 25-31.
26. Pires R, Rolo D, Gama-Norton L et al. Group A streptococci from carriage and disease in Portugal: evolution of antimicrobial resistance and T antigenic types during 2000-2002. Microb Drug Resist 2005; 11: 360-70.
27. Reinert R, Lütticken R, Sutcliffe J et al. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrob Agents Chemother 2004; 48: 1369-73.
28. Creti R, Imperi M, Baldassarri L et al. emm types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years? J Clin Microbiol 2007; 45: 2249-56.
29. Granizo JJ, Aguilar L, Casal J et al. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother 2000; 46: 959-4.
30. Uso de antibióticos en España. Agencia española de medicamentos y productos sanitarios. Ministerio de Sanidad y Consumo. 2006. http://www.aemps.es/profHumana/observatoria/docs/antibioticos.pdf. (10 June 2009, date last accessed).
31. Llor C, Cots JM, Gaspar MJ et al. Antibiotic prescribing over the last 16 years: fewer antibiotics but the spectrum is broadening. Eur J Clin Microbiol Infect Dis 2009; 28: 893-7.
32. Malhotra-Kumar S, Lammens C, Chapelle S et al. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003. Emerg Infect Dis 2005; 11: 939-42.
33. Littauer P, Caugant DA, Sangvik M et al. Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob Agents Chemother 2006; 50: 1896-9.
34. Szczypa K, Sadowy E, Izdebski R et al. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J Antimicrob Chemother 2004; 54: 828-31.
35. Montes M, Orden B, Tamayo E et al. Characterization of the main clones of Streptococcus pyogenes carrying the ermA (subclass TR) gene in Spain. Int J Antimicrob Agents 2006; 28: 408-12.
36. Böhlen LM, Mühlemann K, Dubuis O et al. Outbreak among drug users caused by a clonal strain of group A streptococcus. Emerg Infect Dis 2000; 6: 175-9.
37. Alonso R, Mateo E, Ezpeleta G et al. Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain. Int J Antimicrob Agents 2007; 30: 183-5.